Global Antimicrobial Resistance Surveillance System

Global Antimicrobial Resistance Surveillance System
Name	Global Antimicrobial Resistance Surveillance System
Abbrev	GLASS
Established	2015
Founder	World Health Organization
Scope	International

Global Antimicrobial Resistance Surveillance System

The Global Antimicrobial Resistance Surveillance System provides coordinated monitoring of antibiotic, antiviral, antifungal, and antiparasitic resistance trends. It supports national and international decision-making by aggregating laboratory, clinical, and epidemiological data across countries to inform public health policies, clinical guidelines, and research priorities. The initiative interfaces with multiple global agencies, national ministries, and academic institutions to standardize reporting and enable comparative analyses.

Overview

GLASS was designed to produce standardized, comparable data on antimicrobial resistance from participating countries and territories. It connects national reference laboratories, public health institutes, and clinical surveillance sites to central reporting mechanisms administered by the World Health Organization. The system informs stakeholders such as the Food and Agriculture Organization of the United Nations, the World Organisation for Animal Health, the Joint United Nations Programme on HIV/AIDS, the United Nations Children's Fund, and regional bodies like the European Centre for Disease Prevention and Control and the Pan American Health Organization.

History and Development

The concept emerged amid rising concern after publications by researchers at institutions including Centers for Disease Control and Prevention, London School of Hygiene & Tropical Medicine, Johns Hopkins University, and the Wellcome Trust documented increasing resistance. Early international efforts drew on precedents such as the Global Influenza Surveillance and Response System and multisectoral action frameworks endorsed at summits involving the G20, the United Nations General Assembly, and the World Health Assembly. Formal rollout followed consultations with national ministries of health from countries like United Kingdom, United States, India, China, South Africa, and regional pilots coordinated with agencies such as the African Union and the Association of Southeast Asian Nations.

Objectives and Functions

Primary objectives include monitoring trends in resistant pathogens, guiding antimicrobial stewardship, and supporting diagnostics development by linking data to laboratory networks like the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility Testing. Functions span standardized data collection, quality assurance with reference standards from organizations such as the International Organization for Standardization, capacity building through collaborations with universities such as Harvard University and University of Cape Town, and informing procurement and supply-chain decisions influenced by agencies like the Global Fund and the Bill & Melinda Gates Foundation.

Surveillance Methods and Data Collection

Data sources incorporate clinical microbiology laboratories, sentinel hospitals, community health centers, and research cohorts managed by entities like the MRC Unit The Gambia and the Institut Pasteur. Methods use standardized laboratory protocols referencing guidelines from the Clinical and Laboratory Standards Institute and genomic surveillance supported by platforms from European Bioinformatics Institute and Wellcome Sanger Institute. Data collection involves antimicrobial susceptibility testing, pathogen identification, and patient metadata harmonized with case definitions influenced by the Centers for Disease Control and Prevention and the National Institutes of Health. Reporting cycles align with seasonal and outbreak surveillance coordinated with networks such as Global Outbreak Alert and Response Network.

Governance and Partnerships

Governance is led by the World Health Organization with advisory input from an external technical group comprising representatives from United Nations Environment Programme, Food and Agriculture Organization of the United Nations, World Organisation for Animal Health, national health ministries from Brazil, Kenya, Japan, and Germany, and partners from philanthropic organizations such as the Wellcome Trust and the Bill & Melinda Gates Foundation. Academic partners include London School of Hygiene & Tropical Medicine, Karolinska Institutet, and University of Melbourne. Collaboration extends to laboratory networks like the European Centre for Disease Prevention and Control reference laboratories, pharmaceutical regulators such as the European Medicines Agency, and data platforms like the Global Health Data Exchange.

Impact and Outcomes

GLASS has improved comparability of resistance data for priority pathogens including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, and Neisseria gonorrhoeae. Reported outcomes include enhanced detection of multidrug-resistant organisms, informed national action plans influenced by the WHO Global Action Plan on Antimicrobial Resistance, and contributions to policy debates at forums like the World Health Assembly and the G7. GLASS data have supported research published by institutions such as Imperial College London and aided initiatives by the European Centre for Disease Prevention and Control to revise empirical therapy guidelines.

Challenges and Future Directions

Challenges include heterogeneity in laboratory capacity among countries such as Somalia, Haiti, and Afghanistan, data gaps in low-resource settings, and integration of human and animal surveillance streams emphasized by the One Health approach advocated by the Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health. Future directions prioritize genomic surveillance scaling with partners like the Wellcome Sanger Institute and the European Bioinformatics Institute, expanded collaboration with pharmaceutical research by Pfizer and GSK on diagnostics, and improved data sharing agreements modeled after frameworks negotiated within the World Health Assembly and the United Nations. Enhancing training via programs at Johns Hopkins University and University of Oxford and strengthening linkages to procurement mechanisms such as the Global Fund will be central to sustaining surveillance impact.

Category:Public health